Literature DB >> 16081024

Neuropsychiatric features of systemic lupus erythematosus.

Andrea T Borchers1, Christopher A Aoki, Stanley M Naguwa, Carl L Keen, Yehuda Shoenfeld, M Eric Gershwin.   

Abstract

Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious and well known complication of systemic lupus erythematosus that remains a significant source of morbidity and mortality. Fortunately, advances in neuroimaging techniques and cognitive testing have improved the diagnosis of this disease and allowed earlier and more successful therapeutic intervention. Further, the association of NPSLE with the anti-phospholipid syndrome, other autoantibodies and inflammatory cytokines have also provided clues to the diagnosis and pathophysiology. Treatment of NPSLE is largely symptom based with outcome based on appropriate diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 16081024     DOI: 10.1016/j.autrev.2005.01.008

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

2.  Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.

Authors:  Ji-Bo Wang; Hua Li; Li-Li Wang; Hong-Da Liang; Lei Zhao; Jing Dong
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.

Authors:  Savino Sciascia; Maria Laura Bertolaccini; Dario Roccatello; Munther A Khamashta; Giovanni Sanna
Journal:  J Neurol       Date:  2014-06-21       Impact factor: 4.849

4.  Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line.

Authors:  Abdullah Almamy; Christian Schwerk; Horst Schroten; Hiroshi Ishikawa; Abdul Rahman Asif; Bernhard Reuss
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

Review 5.  The emergency room in systemic rheumatic diseases.

Authors:  G Slobodin; A Hussein; M Rozenbaum; I Rosner
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

6.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

7.  Antibodies and the Brain: Lessons from Lupus.

Authors:  Betty Diamond
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

Review 8.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

9.  Antibodies directed against ribosomal P proteins cross-react with phospholipids.

Authors:  L Caponi; C Anzilotti; G Longombardo; P Migliorini
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

Review 10.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.